TMO - Thermo Fisher Scientific Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5111.94B
Enterprise Value 3128.06B
Trailing P/E 31.92
Forward P/E 120.58
PEG Ratio (5 yr expected) 12.00
Price/Sales (ttm)4.50
Price/Book (mrq)3.90
Enterprise Value/Revenue 35.15
Enterprise Value/EBITDA 620.23

Trading Information

Stock Price History

Beta (3Y Monthly) 1.15
52-Week Change 318.10%
S&P500 52-Week Change 30.90%
52 Week High 3305.45
52 Week Low 3208.34
50-Day Moving Average 3286.08
200-Day Moving Average 3272.24

Share Statistics

Avg Vol (3 month) 31.47M
Avg Vol (10 day) 31.41M
Shares Outstanding 5399.97M
Float 399.4M
% Held by Insiders 10.19%
% Held by Institutions 190.67%
Shares Short (Jul 31, 2019) 42.79M
Short Ratio (Jul 31, 2019) 42.06
Short % of Float (Jul 31, 2019) 40.70%
Short % of Shares Outstanding (Jul 31, 2019) 40.70%
Shares Short (prior month Jun 28, 2019) 42.62M

Dividends & Splits

Forward Annual Dividend Rate 40.76
Forward Annual Dividend Yield 40.28%
Trailing Annual Dividend Rate 30.72
Trailing Annual Dividend Yield 30.26%
5 Year Average Dividend Yield 40.37
Payout Ratio 48.22%
Dividend Date 3Oct 15, 2019
Ex-Dividend Date 4Sep 16, 2019
Last Split Factor (new per old) 22/3
Last Split Date 3Jun 6, 1996

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 29, 2019

Profitability

Profit Margin 14.24%
Operating Margin (ttm)16.42%

Management Effectiveness

Return on Assets (ttm)4.50%
Return on Equity (ttm)12.84%

Income Statement

Revenue (ttm)24.87B
Revenue Per Share (ttm)62.01
Quarterly Revenue Growth (yoy)3.90%
Gross Profit (ttm)10.87B
EBITDA 6.33B
Net Income Avi to Common (ttm)3.54B
Diluted EPS (ttm)8.76
Quarterly Earnings Growth (yoy)48.80%

Balance Sheet

Total Cash (mrq)2.29B
Total Cash Per Share (mrq)5.71
Total Debt (mrq)19.76B
Total Debt/Equity (mrq)68.78
Current Ratio (mrq)1.50
Book Value Per Share (mrq)71.74

Cash Flow Statement

Operating Cash Flow (ttm)4.96B
Levered Free Cash Flow (ttm)3.99B